Brief: Travere Therapeutics Announces Planned Retirement Of Chief Research Officer In 2027
16/06/2026 21:32
BRIEF-Travere Therapeutics Announces Planned Retirement Of Chief Research Officer In 2027 June 16 (Reuters) - Travere Therapeutics Inc TVTX.O:
TRAVERE THERAPEUTICS ANNOUNCES PLANNED RETIREMENT OF CHIEF RESEARCH OFFICER IN 2027
Source text: ID:nBw3lzQRda
Further company coverage: TVTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Travere Therapeutics
See all newsBrief: Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Travere Therapeutics - Receives USPTO Notice Of Allowance For Filspari Patent In FSGS
Brief: Travere Therapeutics Announces Planned Chief Executive Officer Transition
Brief: Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule